查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493356

美国免疫测量市场规模、份额、趋势分析报告：按产品、按技术、按应用、按检体、按最终用途、按地区、细分市场预测，2024-2030 年

U.S. Immunoassay Market Size, Share & Trends Analysis Report By Product (Reagent & Kits, Analyzers/Instruments), By Technology (RIA, ELISA), By Application, By Specimen, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10个工作天内

价格

美国免疫测量市场的成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，美国免疫测量市场预计将达到122.5亿美元，2024年至2030年的复合年增长率为2.8%。

慢性病和感染疾病患者的增加以及对疾病早期检测的需求不断增加是推动市场成长的主要因素。根据国际癌症研究机构的数据，2020年报告了19,292,789例癌症病例，预计2025年这一数字将达到50,550,287例。乳癌、肺癌、大肠癌、摄护腺癌和胃癌是最常见的癌症。

不断增长的老年人口是推动美国市场成长的关键因素。随着越来越多的人达到退休年龄并寻求医疗护理，对免疫测量等诊断测试的需求预计将会增加。此外，自动化、小型化、现场检测设备和先进检测技术等技术进步是免疫测量市场的关键驱动因素。这些创新彻底改变了免疫测量技术，使其更有效率、可靠，并可在医疗保健和研究领域广泛应用。

临床诊断和研究实验室越来越多地采用免疫测量测试，这对美国市场产生了积极影响，推动了市场扩张，推动了检测法开发的创新，并透过早期准确的诊断改善了患者的治疗结果。

美国免疫测量市场报告亮点

  • 到2023年，试剂和套件将以65.82%的收益占有率引领市场，并且由于创新免疫测量套件的引进和批准不断增加，预计在预测期内将以最快的复合年增长率增长。
  • 从应用来看，由于对 HIV、肝炎和 COVID-19 等感染疾病早期检测的免疫测量的需求不断增加，传染病检查领域将在 2023 年以 29.55% 的最大收益占有率占据市场主导地位。
  • 依最终用途划分，医院领域占市场份额最大，2023年销售份额为33.01%。医院被认为是诊断各种疾病的主要医疗机构，这正在推动该领域的成长。
  • 从检体来看，血液细分市场在 2023 年以 43.19% 的最大收益占有率引领市场。这是由于需要这些血液检测程序的疾病发生率不断增加以及该领域的技术进步。
  • 2023年7月，SEKISUI Diagnostics推出了美国製造的OSOM COVID-19抗原家庭检验。此测试可以在家中进行，可能有助于检测 SARS-CoV-2 病毒引起的核衣壳蛋白抗原。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国免疫测量市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 美国免疫测量市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国免疫测量市场：产品评估与趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 按产品分類的美国免疫测量市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 试剂/套件
  • 分析仪/设备
  • 软体服务

第五章美国免疫测量市场：技术评估与趋势分析

  • 2023年及2030年技术市场占有率
  • 细分仪表板
  • 按技术前景分類的美国免疫测量市场
  • 2018-2030年市场规模、预测及趋势分析
  • 免疫测量
  • 酵素连结免疫测量
  • 快速测试
  • 其他的

第六章美国免疫测量市场：应用估算与趋势分析

  • 2023年及2030年应用市场占有率
  • 细分仪表板
  • 美国免疫测量市场应用展望
  • 2018-2030年市场规模、预测及趋势分析
  • 治疗药物监测
  • 肿瘤学
  • 循环系统
  • 内分泌
  • 传染病检查
  • 自体免疫疾病
  • 其他的

第七章美国免疫测量市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的美国免疫测量市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 医院
  • 血库
  • 临床实验室
  • 製药和生物技术公司
  • 学术研究中心

第八章美国免疫测量市场：检体估计与趋势分析

  • 2023 年及 2030 年样本市场占有率
  • 细分仪表板
  • 美国标本免疫测量市场检体
  • 2018-2030年市场规模、预测及趋势分析
  • 血
  • 唾液
  • 尿
  • 其他检体

第九章美国免疫测量市场：区域估计与趋势分析

  • 2023 年和 2030 年按地区分類的市场占有率份额
  • 美国免疫测量市场按地区展望
  • 2018-2030年市场规模、预测及趋势分析
  • 西
  • 中西部
  • 东北
  • 西南
  • 东南

第10章竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
  • 公司简介
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Siemens Healthineers
    • Danaher Corporation
    • Thermo Fisher Scientific
    • Bio-Rad Laboratories
    • Beckman Coulter（a subsidiary of Danaher）
    • Sysmex Corporation
    • DiaSorin
    • Agilent Technologies
Product Code: GVR-4-68040-285-5

U.S. Immunoassay Market Growth & Trends:

The U.S. immunoassay market is anticipated to reach USD 12.25 billion by 2030 and is projected to grow at a CAGR of 2.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of chronic and infectious diseases and rising demand for early detection of diseases are the major factors contributing to the market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020 and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported.

The rising geriatric population is a significant factor driving the market growth in the U.S. As more individuals reach retirement age and require medical care, the demand for diagnostic tests such as immunoassays is expected to rise. Furthermore, technological advancements such as automation, miniaturization, point-of-care testing devices, and advanced detection technologies are key drivers of the immunoassay market. These innovations have revolutionized immunoassay techniques, making them more efficient, reliable, and accessible for a wide range of applications in healthcare and research.

The growing adoption of immunoassay tests in clinical diagnostics and research laboratories has positively impacted the U.S. market by driving market expansion, fostering innovation in assay development, and improving patient outcomes through early and accurate diagnosis.

U.S. Immunoassay Market Report Highlights:

  • Reagents & kits led the market with the largest revenue share of 65.82% in 2023 and are expected to grow at the fastest CAGR over the forecast period, owing to the increasing introduction and approval of innovative immunoassay kits
  • Based on application, the infectious diseases testing segment led the market with the largest revenue share of 29.55% in 2023, due to increasing demand for immunoassays for early detection of infectious diseases such as HIV, hepatitis, COVID-19, and others
  • Based on end-use, the hospital segments held the market with the largest revenue share of 33.01% in 2023. Hospitals are considered primary care facilities for the diagnosis of various diseases, which is driving segment growth
  • Based on specimen, the blood segment led the market with the largest revenue share of 43.19% in 2023, owing to the increasing incidence of diseases requiring these blood testing procedures and technological advancements in the segment
  • In July 2023, SEKISUI Diagnostics introduced the OSOM COVID-19 Antigen Home Test, made in the U.S. The test can be performed at home and is likely to help detect nucleocapsid protein antigen that results from the SARS-CoV-2 virus

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. End-use
    • 1.2.5. Specimen
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Application outlook
    • 2.2.4. End-use outlook
    • 2.2.5. Specimen outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Immunoassay Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Immunoassay Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape

Chapter 4. U.S. Immunoassay Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Immunoassay Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 4.4.1. Reagents & kits
      • 4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. ELISA reagents & kits
      • 4.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Rapid test reagents & kits
      • 4.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.4. ELISPOT reagents & kits
      • 4.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.5. Western blot reagents & kits
      • 4.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.6. Other reagents & kits
      • 4.4.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Analyzers/instruments
      • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.2. Open ended systems
      • 4.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.3. Closed ended systems
      • 4.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Software & Services
      • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Immunoassay Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Immunoassay Market by Technology Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 5.4.1. Radioimmunoassay (RIA)
      • 5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Enzyme Immunoassays (EIA)
      • 5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.2.2. Chemiluminescence Immunoassays (CLIA)
      • 5.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.2.3. Fluorescence Immunoassays (FIA)
      • 5.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Rapid test
      • 5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. U.S. Immunoassay Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Immunoassay Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 6.4.1. Therapeutic drug monitoring
      • 6.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Oncology
      • 6.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. Cardiology
      • 6.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.4. Endocrinology
      • 6.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.5. Infectious disease testing
      • 6.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.6. Autoimmune diseases
      • 6.4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.7. Others
      • 6.4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. U.S. Immunoassay Market: End-use Estimates & Trend Analysis

  • 7.1. End-use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. U.S. Immunoassay Market by End-use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 7.4.1. Hospitals
      • 7.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Blood banks
      • 7.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Clinical laboratories
      • 7.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Pharmaceutical and biotech companies
      • 7.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.5. Academic research centers
      • 7.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.6. Others
      • 7.4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. U.S. Immunoassay Market: Specimen Estimates & Trend Analysis

  • 8.1. Specimen Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. U.S. Immunoassay Market by Specimen Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 8.4.1. Blood
      • 8.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. Saliva
      • 8.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. Urine
      • 8.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. Other specimens
      • 8.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. U.S. Immunoassay Market: Region Estimates & Trend Analysis

  • 9.1. Regional Market Share, 2023 & 2030
  • 9.2. U.S. Immunoassay Market by Region Outlook
  • 9.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 9.3.1. West
      • 9.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.2. Midwest
      • 9.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.3. Northeast
      • 9.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.4. Southwest
      • 9.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.5. Southeast
      • 9.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company heat map analysis, 2023
  • 10.4. Company Profiles
    • 10.4.1. F. Hoffmann-La Roche AG
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Abbott Laboratories
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Siemens Healthineers
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Danaher Corporation
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Thermo Fisher Scientific
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Bio-Rad Laboratories
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Beckman Coulter (a subsidiary of Danaher)
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Sysmex Corporation
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. DiaSorin
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Agilent Technologies
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. immunoassay market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. immunoassay market, by technology, 2018 - 2030 (USD Million)
  • Table 4 U.S. immunoassay market, by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. immunoassay market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. immunoassay market, by specimen, 2018 - 2030 (USD Million)
  • Table 7 U.S. immunoassay market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. immunoassay market: Market outlook
  • Fig. 9 U.S. immunoassay competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. immunoassay market driver impact
  • Fig. 14 U.S. immunoassay market restraint impact
  • Fig. 15 U.S. immunoassay market: Product movement analysis
  • Fig. 16 U.S. immunoassay market: Product outlook and key takeaways
  • Fig. 17 Reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Elisa reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Rapid test reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Elispot reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Western blot reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Other reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Analyzers/Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Open ended systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Closed ended systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Software & services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. immunoassay Market: Technology movement Analysis
  • Fig. 28 U.S. immunoassay market: Technology outlook and key takeaways
  • Fig. 29 Radioimmunoassay (RIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Enzyme Immunoassays (EIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Chemiluminescence Immunoassays (CLIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Fluorescence Immunoassays (FIA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Rapid test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. immunoassay market: Application movement analysis
  • Fig. 36 U.S. immunoassay market: Application outlook and key takeaways
  • Fig. 37 Therapeutic drug monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Endocrinology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Infectious disease testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Autoimmune diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. immunoassay market: End-use movement analysis
  • Fig. 45 U.S. immunoassay market: End-use outlook and key takeaways
  • Fig. 46 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Blood banks market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Pharmaceutical and biotech companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Academic research centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. immunoassay market: Specimen movement analysis
  • Fig. 53 U.S. immunoassay market: Specimen outlook and key takeaways
  • Fig. 54 Blood market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saliva market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Other specimens market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 U.S. immunoassay market: Regional movement analysis
  • Fig. 59 U.S. immunoassay market: Regional outlook and key takeaways
  • Fig. 60 West market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)